Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Anton Gillessen, Hartmut Schmidt
Advances in Therapy (2020) Vol. 37, Iss. 4, pp. 1279-1301
Open Access | Times Cited: 352

Showing 26-50 of 352 citing articles:

Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice
Xin Wang, Yufeng Jin, Can Di, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1169-1169
Open Access | Times Cited: 8
The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency
George J. Kontoghiorghes
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4654-4654
Open Access | Times Cited: 8
Near-Infrared Fluorescent Probe Reveals Elevated Mitochondrial Viscosity during Acute Alcoholic Liver Injury
Xiaodong Tan, Jiaxin Hong, Siyu Jiang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 37, pp. 14860-14866
Closed Access | Times Cited: 8
Silymarin is an ally against insulin resistance: A review
Karla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, et al.
Annals of Hepatology (2020) Vol. 23, pp. 100255-100255
Open Access | Times Cited: 55
Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, et al.
Life Sciences (2021) Vol. 271, pp. 119220-119220
Closed Access | Times Cited: 52
A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases
Devaraj Ezhilarasan, Lakshmi Thangavelu
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 36
Tea saponins as natural emulsifiers and cryoprotectants to prepare silymarin nanoemulsion
Mao Deng, Huijuan Chen, Long Xie, et al.
LWT (2022) Vol. 156, pp. 113042-113042
Open Access | Times Cited: 34
Green Synthesis of Silymarin–Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis
Abdullah Saad Abdullah, Ibrahim El Tantawy El Sayed, Abdel Moneim El‐Torgoman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5420-5420
Open Access | Times Cited: 30
Effect of natural polysaccharides on alcoholic liver disease: A review
Siyu Li, Xin Zhou, Ruhai Chen, et al.
International Journal of Biological Macromolecules (2023) Vol. 251, pp. 126317-126317
Closed Access | Times Cited: 19
Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review
Ernesto Calderón Martinez, Domenica Herrera, Saruveish Mogan, et al.
Cureus (2023)
Open Access | Times Cited: 18
Silibinin alleviates ferroptosis of rat islet β cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1/parkin-mediated mitophagy
Qingqing Du, Xiaoyun Wu, Kai Ma, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 743, pp. 109644-109644
Closed Access | Times Cited: 17
Hepatoprotective effects of natural drugs: Current trends, scope, relevance and future perspectives
Sonal Datta, Diwakar Aggarwal, Nirmala Sehrawat, et al.
Phytomedicine (2023) Vol. 121, pp. 155100-155100
Closed Access | Times Cited: 17
Modulation of the gut microbiome and Firmicutes phylum reduction by a nutraceutical blend in the obesity mouse model and overweight humans: A double‐blind clinical trial
Victor Nehmi‐Filho, Jéssica Alves de Freitas, Lucas Augusto Moysés Franco, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 4, pp. 2436-2454
Open Access | Times Cited: 5
Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress
Karthik Shree Harini, Devaraj Ezhilarasan
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105467-105467
Closed Access | Times Cited: 5
Adjunctive silymarin supplementation and its effects on disease severity, oxidative stress, and inflammation in patients with Alzheimer’s disease
Seyed Mohammad Navabi, Daniel Elieh Ali Komi, Daryoush Afshari, et al.
Nutritional Neuroscience (2024) Vol. 27, Iss. 10, pp. 1077-1087
Closed Access | Times Cited: 5
Silibinin’s Effects against Methotrexate-Induced Hepatotoxicity in Adjuvant-Induced Arthritis Rat Model
Ghada Khawaja, Youmna El-Orfali
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 431-431
Open Access | Times Cited: 5
Complementary and alternative medicines and liver disease
Cyriac Abby Philips, Arif Hussain Theruvath, R. D. Ravindran, et al.
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 5
Dietary silymarin improves performance by altering hepatic lipid metabolism and cecal microbiota function and its metabolites in late laying hens
Guo Yang-hao, Yudong Xu, Derun Wang, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Abnormalities in Blood Parameters in Athletes Taking Anabolic Androgenic Steroidal Agents; an Observational Clinical Study
Ghaida Siraj Mubarak, Ghazi A. Bamagous, Safaa Alsanosi, et al.
Substance Abuse and Rehabilitation (2025) Vol. Volume 16, pp. 1-12
Open Access
Especies vegetales para las alteraciones hepatobiliares: cardo mariano
Marta Sánchez, M. Pilar Gómez‐Serranillos
Panorama actual del medicamento (2025), pp. 139-145
Closed Access
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Multidrug Resistance Modulation Activity of Silybin Derivatives and Their Anti-Inflammatory Potential
Simona Dobiasová, Kateřina Řehořová, Denisa Kučerová, et al.
Antioxidants (2020) Vol. 9, Iss. 5, pp. 455-455
Open Access | Times Cited: 47
Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials
Hao Niu, Judith Sanabria‐Cabrera, Ismael Álvarez‐Álvarez, et al.
Pharmacological Research (2020) Vol. 164, pp. 105404-105404
Open Access | Times Cited: 44
The Role of Natural Antioxidants in the Prevention of Dementia—Where Do We Stand and Future Perspectives
Anamaria Jurcău
Nutrients (2021) Vol. 13, Iss. 2, pp. 282-282
Open Access | Times Cited: 39
Lung Cancer Management with Silibinin: A Historical and Translational Perspective
Sara Verdura, Elisabet Cuyàs, Verónica Ruiz-Torres, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 559-559
Open Access | Times Cited: 35

Scroll to top